Casdin Capital, LLC is Director of 2seventy bio, Inc.. Currently has a direct ownership of 22,625 shares of TSVT, which is worth approximately $89,368. The most recent transaction as insider was on Jun 10, 2024, when has been sold 6,025 shares (Common Stock, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.6K
n/a 3M change
n/a 12M change
Total Value Held $89,368

Casdin Capital, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2024
BUY
Grant, award, or other acquisition
-
6,025 Added 21.03%
22,625 Common Stock, par valu...

Also insider at

CNST
CONSTELLATION PHARMACEUTICALS INC Healthcare
FULC
Fulcrum Therapeutics, Inc. Healthcare
GBIO
Generation Bio Co. Healthcare
SMFR
Sema4 Holdings Corp. Healthcare
CCL

Casdin Capital, LLC

Director
New York, NY

Track Institutional and Insider Activities on TSVT

Follow 2seventy bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSVT shares.

Notify only if

Insider Trading

Get notified when an 2seventy Bio, Inc. insider buys or sells TSVT shares.

Notify only if

News

Receive news related to 2seventy bio, Inc.

Track Activities on TSVT